Old-hat in­vestors Al­ta Part­ners snag $275M for their newest next-gen fund, more than dou­ble the first it­er­a­tion from 2018

Al­ta Part­ners has seen it all over the course of more than 20 years in biotech in­vest­ing, but that doesn’t mean they aren’t still look­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.